
BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Neuroendocrine Cancer Awareness Network - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://netcancerawareness.org
X-WR-CALDESC:Events for Neuroendocrine Cancer Awareness Network
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250901T000000
DTEND;TZID=America/New_York:20251231T233000
DTSTAMP:20260429T002131
CREATED:20250115T191954Z
LAST-MODIFIED:20250904T152659Z
UID:20820-1756684800-1767223800@netcancerawareness.org
SUMMARY:2025 Virtual "Stride For Stripes" Zebra Walk
DESCRIPTION:Step up. Speak out. Make a difference.\n \nJoin us for a powerful event that brings hope to thousands battling Neuroendocrine and Carcinoid Cancer (NET). \nWhether you walk in memory\, in honor\, or in support—your steps matter. \nREGISTER TO PARTICIPATESPONSOR A WALKERSPONSOR THE EVENT \n\nWhy Walk?\nNo NET patient should ever fight alone. \nAwareness saves lives. \nYour support fuels programs like the NET Cancer Hotline\, Patient Conferences\, and Support Groups. \n\nHow to Be Part of the Movement.\n \nRegister to Participate – Walk anytime\, anywhere between now and November 26th.Sponsor a Participant – Make a tax-deductible gift to support their journey.Sponsor the Event – Showcase your business or family’s commitment. \n\nChoose Your Walk.\n1. Virtual Walk\n \nSign up anytime before November 26th. Walk wherever and whenever works for you—alongside hundreds of others walking for the same cause. \n2. 2025 “Strides for Stripes” Carolina Zebra Walk\n \nCherry Park\, Open Shelter\, Rock Hill\, SCSunday\, Nov 2 | 11:30 AM – 3 PM ET (Rain or shine!)Register by Oct 14 to receive your T-shirt in time \n\nImportant Info.\n \nWant a T-shirt and/or beanie? You must Register to Participate \nLast day for T-shirt/Beanie delivery: Nov 14 \nDonations accepted through Dec 31\, 2025 \n\nOur Mission.\nSince 2003\, NCAN has worked tirelessly to improve the lives of those affected by NETs through education\, support\, and advocacy. \nWith every stride\, we bring hope. With every donation\, we change lives. \nLet’s walk together. Let’s walk with purpose. \nREGISTER TO PARTICIPATE NOW \n\n\n\n\n#StridesForStripes #NeuroendocrineCancer #NeuroendocrineTumor #NETs #ZebraStrong #NETCancerAwareness #NCAN #CancerSupport #NoOneFightsAlone
URL:https://netcancerawareness.org/event/2025-virtual-stride-for-stripes-zebra-walk/
LOCATION:NY
CATEGORIES:NCAN Upcoming Events for 2025
ATTACH;FMTTYPE=image/jpeg:https://netcancerawareness.org/wp-content/uploads/2025/01/ncan_fb_25_virtualstrides4stripes2.jpg
ORGANIZER;CN="Robert Wahmann":MAILTO:bob@netcancerawareness.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250921T080000
DTEND;TZID=America/New_York:20250921T170000
DTSTAMP:20260429T002131
CREATED:20250115T193820Z
LAST-MODIFIED:20250908T221352Z
UID:20832-1758441600-1758474000@netcancerawareness.org
SUMMARY:NCAN 2025 New Jersey NET Patient Conference
DESCRIPTION:Date: Sunday September 21\, 2025\nTime: 8 AM to 5 PM EST\nLocation: Jack & Sheryl Morris Cancer Center\nAddress: 165 Somerset Street\, New Brunswick\, NJ  \nREGISTER TODAY! \n\nJoin Us and: \n\nMeet the Pioneers: Engage with leading experts who treat neuroendocrine cancer. \nExplore Innovations: Speak with representatives from top labs\, medical centers\, and pharmaceutical companies in the NET field. \nConnect & Share: Network with fellow patients and caregivers who truly understand your journey. \nDon’t miss this incredible opportunity to gain insights\, support\, and hope. \nRegister for an NCAN patient conference and be part of a community dedicated to making a difference! \n\n\n\n\nSo Many NET Experts In One Place! \nAn impressive panel of speakers featuring some of the TOP NET specialists in the US. \n\n\n\n\nHoward Hochster\, MD: Dr. Hochster is a nationally recognized medical oncologist and Associate Director for Clinical Research and Director of Gastrointestinal (GI) Oncology at Rutgers Cancer Institute. He is also Director of Oncology Research\, RWJBarnabas Health\, with a focus on advancing treatment through clinical trials. His research has contributed to the approval of multiple therapies for GI cancers\, including neuroendocrine tumors. Dr. Hochster has authored over 150 peer-reviewed publications and leads national efforts in cancer research through the NCI and SWOG.\nMary Maluccio\, MD: Dr. Maluccio is a surgical oncologist and Director of the Rare Cancer Program and New Orleans Neuroendocrine Tumor Specialists (NOLANETS) at LSU Health Sciences Center. She specializes in complex surgical care for rare cancers\, with a strong focus on both primary and metastatic neuroendocrine tumors. A leader in translational research\, Dr. Maluccio serves as principal investigator on multiple clinical trials and is dedicated to improving diagnosis\, treatment\, and access to care for patients with rare and challenging cancers.\nNamrata Vijayvergia\, MD: Dr. Vijayvergia is Assistant Chief of Gastrointestinal Medical Oncology and Medical Director of Medical Oncology at Fox Chase Cancer Center in Philadelphia. She specializes in the treatment of neuroendocrine tumors and other gastrointestinal cancers\, with a strong focus on developing new therapies and identifying biomarkers to improve patient outcomes. Her research includes studying the molecular profile of neuroendocrine tumors to discover targeted treatments. Dr. Vijayvergia is nationally recognized for her contributions to clinical care and research\, and actively serves on panels for the NCCN\, NCI\, and ECOG \nMiral Grandhi\, MD: Dr. Grandhi is a surgical oncologist and Director of Hepatobiliary Surgery at Rutgers Cancer Institute. She specializes in gastrointestinal surgical oncology with a focus on liver\, pancreas\, bile duct\, and gastric tumors\, including neuroendocrine tumors. Trained at Johns Hopkins Hospital\, she is skilled in advanced laparoscopic and robotic techniques. Dr. Grandhi is actively involved in clinical research and is committed to improving outcomes and quality of life for patients through multidisciplinary care and innovation.\nMiriam Eskander\, MD\, MPH: Dr. Eskander is a surgical oncologist at Rutgers Cancer Institute\, specializing in gastrointestinal cancers including pancreatic\, liver\, and bile duct tumors. She has expertise in both open and robotic surgery. Her research focuses on cancer care delivery and improving access to clinical trials for vulnerable populations. She has over 60 peer-reviewed publications. She is a member of the GI disease site working group for the Society of Surgical Oncology and serves of the editorial board for the Annals of Surgical Oncology journal. \n\n\n\n\n\n\n\n\n\n\n\nNCAN and Rutgers Cancer Institute collaborate to bring you a conference where you can build your NET knowledge. \n  \n\n\n\n \n\n\n\n\n\nRutgers Cancer Institute offers access to innovative clinical trials for patients with endocrine and neuroendocrine tumors. These trials are part of their Endocrine and Neuroendocrine Tumor Program\, which provides trials involving targeted therapies and immunotherapies.\n\n\nResearch HighlightsDr. Steven K. Libutti\, William N. Hait Director of Rutgers Cancer Institute and Senior Vice President of Oncology Services\, RWJBarnabas Health\, is leading a major research initiative. His work focuses on: \n\n\nInvestigating a novel immune checkpoint molecule called B7x\nExploring how B7x may suppress the immune system’s ability to attack pancreatic NET\nDeveloping new immunotherapy strategies for NETs\n\nThis research is conducted in the Nancy Scott Amick Memorial Laboratory for Cancer Research\, supported by philanthropic gifts. \nAdditional Innovations \nRutgers Cancer Institute is also exploring immunotherapy options specifically for carcinoid tumors and pancreatic NETs\, addressing the limited treatment options currently available. \nClinical Program \nIn its Multidisciplinary Endocrine and Neuroendocrine Tumor Program\, Rutgers Cancer Institute offers a comprehensive\, team-based approach to treating NETs.\n\n\n\n\nDon’t Miss Out!\nJoin us for this transformative experience. Together\, we can learn\, grow\, and advocate for better care and awareness. \nREGISTER TODAY to secure your spot!\n\n \nWe Can Help You Attend NCAN Conferences.\n\nIf you are a patient or caregiver\, and want to attend an NCAN conference but are concerned about the cost\, please email us. The Woltering NET Patient Scholarship is a donation-based program\, and grants will be available as funding allows. \nFor information or to apply\, email us at bob@netcancerawareness.org
URL:https://netcancerawareness.org/event/ncan-2025-new-jersey-net-patient-conference/
LOCATION:NY
CATEGORIES:NCAN Upcoming Events for 2025
ATTACH;FMTTYPE=image/jpeg:https://netcancerawareness.org/wp-content/uploads/2025/01/newjersey_netpatconf25bnr3.jpg
ORGANIZER;CN="Robert Wahmann":MAILTO:bob@netcancerawareness.org
END:VEVENT
END:VCALENDAR